Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Multiplex Biomarker Imaging Market Between 2025 And 2029?
The multiplex biomarker imaging market has experienced considerable expansion in recent years. This market is set to expand from $0.49 billion in 2024 to $0.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.7%. Historically, this growth has been driven by factors such as the high occurrence of cancer, the requirement for accurate diagnostic instruments, the increasing prevalence of chronic conditions, an expanding aging demographic, and the transition towards personalized healthcare approaches.
The multiplex biomarker imaging market is projected to experience swift expansion over the coming years. By 2029, its value is anticipated to reach $0.8 billion, demonstrating a compound annual growth rate (CAGR) of 10.1%. This anticipated growth during the forecast period stems from factors such as a heightened focus on personalized medicine, an increase in research and development initiatives, a rise in clinical trials, the demand for high-throughput screening techniques in drug discovery, and favorable regulatory structures and guidelines. Key trends identified for the forecast period encompass ongoing technological advancements, breakthroughs in imaging technologies, progress in digital pathology, enhancements in data analysis and imaging software, and the incorporation of artificial intelligence and machine learning into imaging technologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16127&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Multiplex Biomarker Imaging Industry?
The multiplex biomarker imaging market is poised for growth due to the escalating incidence of chronic illnesses. These conditions are long-term health issues that persist or reoccur over time, often characterized by intricate origins, multiple contributing factors, and extended latency periods. The rising prevalence of chronic diseases is attributed to several elements, including a rapidly aging population, improved methods for identifying and detecting cases, enhanced disease treatment and management, and shifts in lifestyle and environmental risk factors. Multiplex biomarker imaging is employed in managing chronic diseases to provide comprehensive analysis and detailed characterization of disease progression and treatment efficacy. For instance, in January 2023, a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, indicated that the population aged 50 and older with at least one chronic illness is expected to increase by 99.5%, from 71.52 million in 2020 to 142.66 million in 2050. Thus, the increasing occurrence of chronic diseases is a significant catalyst for the expansion of the multiplex biomarker imaging market.
What Are The Different Segment Classifications Within The Multiplex Biomarker Imaging Market?
The multiplex biomarker imagingmarket covered in this report is segmented –
1) By Component Type: Instruments; Software; Services
2) By Imaging Techniques: Immuno Fluorescence (IF) Assay; Tissue Microarray (TMA) Assay; Immunohistochemistry (IHC) Assay; Fluorescent In The Situ Hybridization (FISH) Assay; Toponome Imaging System (TIS)
3) By Application: Drug Safety; Oncology Studies; Genetic Characterization Studies
4) By End User: Research Institutes Government And Private; Clinical Labs; Pharmaceutical And Biotechnology
Subsegments:
1) By Instruments: Imaging Systems (Microscopes, Scanners); Detection Devices (Sensors, Probes); Reagents And Kits
2) By Software: Image Analysis Software; Data Management Software; Visualization And Interpretation Software
3) By Services: Technical Support And Maintenance; Consultation And Training; Imaging And Analysis Services
Which Key Trends Are Expected To Influence The Multiplex Biomarker Imaging Market In The Coming Years?
Leading companies within the multiplex biomarker imaging market are concentrating on introducing innovative slides, including automated slide loaders, to offer advanced imaging solutions and better cater to their clientele. Automated slide loaders are instrumental in streamlining sample management, decreasing the time spent on manual tasks, and boosting throughput, all of which are essential for high-volume multiplex biomarker imaging experiments. As an illustration, in April 2024, Standard BioTools Inc., an analytical systems and instruments provider based in the US, unveiled its Hyperion XTi Imaging System, which incorporates a new high-throughput multiplexed whole slide to provide increased automation and flexibility. The system features three modes for rapid analysis: preview, tissue, and cell modes. Researchers can quickly observe tissue heterogeneity and conduct more profound analyses. This novel whole slide imaging approach, utilizing imaging mass cytometry (IMC), delivers up to 10 times higher throughput than cyclic immunofluorescent imaging. Additionally, the new automated slide loader facilitates high-throughput imaging, reduces hands-on time, and enables standardization. These innovations are geared towards accelerating breakthroughs in spatial proteomics, thereby offering reliable insights into health and disease.
Which Major Industry Participants Are Leading The Multiplex Biomarker Imaging Market Growth?
Major companies operating in the multiplex biomarker imaging market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher corporation, Becton Dickinson and Company (BD), Carl Zeiss AG, Illumina Inc, PerkinElmer Inc., Bio-Rad Laboratories Inc, Bruker Corporation, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Abcam Plc, Meso Scale Diagnostics LLC, Fluidigm Corporation, NanoString Technologies, Quanterix Corporation, Akoya Biosciences, Enzo Biochem Inc, Cisbio Bioassays, Flagship Biosciences, Aushon BioSystems Ltd, Ionpath Inc., Biosims Technologies
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report
How Does The Multiplex Biomarker Imaging Market Perform Across Key Geographic Regions?
North America was the largest region in the multiplex biomarker imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex biomarker imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Multiplex Biomarker Imaging Market Report:
https://www.thebusinessresearchcompany.com/customise?id=16127&type=smp
Browse Through More Reports Similar to the Global Multiplex Biomarker Imaging Market 2025, By The Business Research Company
Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Renal Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Cancer Biomarker Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model